Gael Lecellier and Catherine Brenner Pages 875 - 881 ( 7 )
Screening strategies of therapeutic molecules and targets have received increasing attention during the past few years. Indeed, identification of novel compounds and drug targets involved in apoptosis control is a major rate-limiting step in anticancer drug development efforts. In this review, we discuss the current screening methodologies to discover novel potential therapeutics targets and drugs implicated in the apoptotic pathway, in particular the intrinsic pathway. In addition, we present a proteomic screening strategy that led us to identify a mitochondrial glutathione-S-transferase as a novel regulator of the pro-apoptotic adenine nucleotide translocase pore function.
Cell death,Mitochondria,Permeability transition pore,Glutathione S-transferase
, CNRS UMR8159,Universite de Versailles/SQY, 45, avenue des Etats-Unis, 78035 Versailles, France.